Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 58 of the 59 references it cites were found in a registry or an index; 24 of the 50 sources its claims cite were checked for support.

The potential of respiration inhibition as a new approach to combat human fungal pathogens

Open access

Abstract

The respiratory chain has been proposed as an attractive target for the development of new therapies to tackle human fungal pathogens. This arises from the presence of fungal-specific electron transport chain components and links between respiration and the control of virulence traits in several pathogenic species. However, as the physiological roles of mitochondria remain largely undetermined with respect to pathogenesis, its value as a potential new drug target remains to be determined. The use of respiration inhibitors as fungicides is well developed but has been hampered by the emergence of rapid resistance to current inhibitors. In addition, recent data suggest that adaptation of the human fungal pathogen, Candida albicans, to respiration inhibitors can enhance virulence traits such as yeast-to-hypha transition and cell wall organisation. We conclude that although respiration holds promise as a target for the development of new therapies to treat human fungal infections, we require a more detailed understanding of the role that mitochondria play in stress adaption and virulence.

Overview

CoChat Summary

TL;DR

This review argues that the fungal respiratory chain is a promising but unproven target for new antifungals, because fungal-specific electron transport chain components exist and respiration is linked to virulence traits. However, resistance, host toxicity concerns, and evidence that respiration-inhibitor adaptation can enhance Candida albicans virulence mean more detailed understanding of mitochondrial stress adaptation is needed.

Key findings

  • Invasive candidaemia carries mortality up to 40%, and resistance to current antifungals plus inherently resistant species such as Candida glabrata and Candida auris drive the need for new targets.
  • Most fungal pathogens have classical respiratory Complexes I–IV plus a cyanide-insensitive alternative oxidase (AOX); C. glabrata lacks multi-subunit Complex I and AOX, and a third “parallel” ETC pathway in C. parapsilosis and C. albicans represents approximately 10% of total respiration capacity.
  • Respiration inhibition can be fungistatic/fungicidal and synergistic with existing antifungals: a screen of a 300,000-compound library identified a fungal-specific Complex III inhibitor that was synergistic with fluconazole, and Complex III/AOX inhibition enhanced caspofungin susceptibility in C. parapsilosis.
  • In the authors’ recent study, C. albicans pretreated with sodium nitroprusside (NO donor) plus salicylhydroxamic acid (SHAM) showed faster hyphal switching when inhibition was relieved and increased virulence in a mouse systemic candidiasis model, with higher kidney fungal burden and increased immune infiltrate; an aoxΔ mutant did not show the increased hyphal switching.

Methods

  • Narrative review synthesizing published literature on fungal respiration, electron transport chain complexes I–IV, alternative oxidase, respiration inhibitors, and combinations with current antifungals.
  • The paper discusses mechanistic and preclinical studies across fungal pathogens including C. albicans, C. glabrata, Aspergillus fumigatus, Cryptococcus neoformans, Candida parapsilosis, and Pneumocystis jirovecii.
  • It also cites the authors’ recent experimental study using C. albicans treated with SNP and SHAM, including a mouse model of systemic candidiasis; no new primary data are reported in this review.

Limitations

  • The paper states that the physiological roles of mitochondria in pathogenesis remain largely undetermined, that the value of respiration as a drug target remains to be determined, and that a more detailed understanding of mitochondrial roles in stress adaptation and virulence is required.
  • It states that conservation of respiratory machinery in eukaryotes raises toxicity concerns, that rapid resistance to current respiration inhibitors is a problem, and that development of fungal AOX inhibitors is hampered by lack of suitable fungal and highly specific inhibitors and by only Trypanosoma brucei AOX structure being available.
  • Evident from the text: this is a narrative review without a stated systematic search or meta-analysis, so its conclusions depend on selected cited studies and on the authors’ prior experimental work rather than on newly generated or systematically appraised evidence.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1007/s00294-019-01001-w

Cites

58 of 58 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Fig. 1 Inhibitors of the fungal electron transport chain. The majority of fungal pathogens possess the classical respiratory chain consisting of Complexes I–IV, as well as an alternative oxidase (AOX). Inhibitors of each component are shown. Respiration inhibition inhibits growth and leads to cell wall remodelling in C. albicans but enhances virulence if inhibition is relieved following adaptation. SDH succinate dehydrogenase, TTFA 2-thenoyltrifluoroacetone, NO nitric oxide
Fig. 1 Inhibitors of the fungal electron transport chain. The majority of fungal pathogens possess the classical respiratory chain consisting of Complexes I–IV, as well as an alternative oxidase (AOX). Inhibitors of each component are shown. Respiration inhibition inhibits growth and leads to cell wall remodelling in C. albicans but enhances virulence if inhibition is relieved following adaptation. SDH succinate dehydrogenase, TTFA 2-thenoyltrifluoroacetone, NO nitric oxideCC BY · PubMed Central

Verification

Claims the paper makes

23 Valid · 3 Not valid · 19 Not checked · 16 Own results and interpretations

31 more claims · 12 with their cited sources checked

Create a free account to see all 61 claims and to verify the 4 references still open.

See all claims — free account
  • It may state two separate claims as one. 23
  • Probably not a substantial claim. 6

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

1 more claim about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

1 of 1

Citations

Cites

Show all 59 references

Cited by

See all 52

Metadata

Authors
Duvenage, L., Munro, C. A., & Gourlay, C. W.
Affiliations
  • University of Kent (GB)
  • University of Aberdeen (GB)
Corresponding author
Gourlay, Campbell W.
Venue
Current Genetics
Published
2019-06-06
Volume
65
Issue
6
Pages
1347-1353
ISSN
  • 0172-8083 (ISSN-L)
  • 1432-0983
OpenAlex
W2950242080
Cited by
52
References
59
Citations by year
2026: 5 · 2025: 10 · 2024: 7 · 2023: 7 · 2022: 6 · 2021: 12 · 2020: 5
FWCI
0.77
Type
journal article
Language
en
Open access
Licence
Locations
  • Current Genetics (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Kent Academic Repository (University of Kent) (submittedVersion, cc-by)
  • Aberdeen University Research Archive (Aberdeen University) (submittedVersion)
Funders
Wellcome (097377/Z/11/Z)
Topics
  • Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
Keywords
respiration inhibition, electron transport chain, human fungal pathogens, Candida albicans, mitochondria, therapeutic target, fungicides, drug resistance, virulence, yeast-to-hypha transition, stress adaptation
MeSH terms
Antifungal Agents, Candida albicans, Electron Transport Complex IV, Drug Therapy, Combination, Fungi, Humans, Mitochondria, Mycoses, Oxidoreductases, Electron Transport Complex III, Virulence, Electron Transport Complex II, Electron Transport Complex I

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The potential of respiration inhibition as a new approach to combat human fungal pathogens. https://app.cochat.ai/papers/10.1007/s00294-019-01001-w
The paper
Duvenage, L., Munro, C. A., & Gourlay, C. W. (2019). The potential of respiration inhibition as a new approach to combat human fungal pathogens. Current Genetics. https://doi.org/10.1007/s00294-019-01001-w

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.